Krishna Institute of Medical Sciences Limited
Symbol: KIMS.BO
BSE
1965.3
INRTržní cena dnes
47.3931
Poměr P/E
2.1584
Poměr PEG
157.28B
MRK Cap
- 0.00%
Výnos DIV
Krishna Institute of Medical Sciences Limited (KIMS-BO) finanční výkazy
Rozvaha
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1706.5 | 1899.9 | 2842.5 | ||||||||
balance-sheet.row.short-term-investments | 0 | 1090.4 | 1643.5 | 2321.2 | ||||||||
balance-sheet.row.net-receivables | 0 | 2718.9 | 1479.4 | 1373.8 | ||||||||
balance-sheet.row.inventory | 0 | 428.6 | 364.3 | 240.8 | ||||||||
balance-sheet.row.other-current-assets | 0 | 114.7 | 101.7 | 27.3 | ||||||||
balance-sheet.row.total-current-assets | 0 | 4776.4 | 3934 | 4511.9 | ||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 18575.1 | 9094.3 | 8308 | ||||||||
balance-sheet.row.goodwill | 0 | 3080.1 | 847.8 | 847.8 | ||||||||
balance-sheet.row.intangible-assets | 0 | 777.4 | 317.6 | 247.4 | ||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 3857.4 | 1165.3 | 1095.2 | ||||||||
balance-sheet.row.long-term-investments | 0 | 61.7 | 3338.1 | 192.2 | ||||||||
balance-sheet.row.tax-assets | 0 | 401.9 | 32.1 | 29.4 | ||||||||
balance-sheet.row.other-non-current-assets | 0 | 1740.5 | 1509.6 | 224.8 | ||||||||
balance-sheet.row.total-non-current-assets | 0 | 24636.7 | 15139.5 | 9849.6 | ||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.total-assets | 0 | 29413 | 19073.5 | 14361.5 | ||||||||
balance-sheet.row.account-payables | 0 | 1742.5 | 1295.3 | 1318.7 | ||||||||
balance-sheet.row.short-term-debt | 0 | 445.8 | 302.1 | 884.3 | ||||||||
balance-sheet.row.tax-payables | 0 | 0 | 1.7 | 87 | ||||||||
balance-sheet.row.long-term-debt-total | 0 | 6335.9 | 2263.2 | 2279.4 | ||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 12.4 | ||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||
balance-sheet.row.other-current-liab | 0 | 606.7 | 417.5 | 442.1 | ||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 7068.7 | 2817 | 2816.3 | ||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.capital-lease-obligations | 0 | 1449.6 | 955 | 459 | ||||||||
balance-sheet.row.total-liab | 0 | 10033.4 | 4967.1 | 5599.6 | ||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.common-stock | 0 | 800.3 | 800.3 | 775.9 | ||||||||
balance-sheet.row.retained-earnings | 0 | 5382.8 | 2674.8 | -644.3 | ||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 11140.6 | 11140.6 | 9224 | ||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | -628.4 | -742.6 | -718.3 | ||||||||
balance-sheet.row.total-stockholders-equity | 0 | 16695.4 | 13873.1 | 8637.3 | ||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 29413 | 19073.5 | 14361.5 | ||||||||
balance-sheet.row.minority-interest | 0 | 2684.2 | 233.3 | 124.6 | ||||||||
balance-sheet.row.total-equity | 0 | 19379.6 | 14106.4 | 8762 | ||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||
Total Investments | 0 | 566.9 | 3331.7 | 24.3 | ||||||||
balance-sheet.row.total-debt | 0 | 6781.7 | 2565.3 | 3163.7 | ||||||||
balance-sheet.row.net-debt | 0 | 6165.6 | 2308.9 | 2642.4 |
Výkaz peněžních toků
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 4849.1 | 4568.5 | 2790.2 | ||||||||
cash-flows.row.depreciation-and-amortization | 0 | 1292.6 | 726.7 | 695.4 | ||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.change-in-working-capital | 0 | -692.8 | -744.7 | 141.5 | ||||||||
cash-flows.row.account-receivables | 0 | -628.1 | -232.7 | 177.5 | ||||||||
cash-flows.row.inventory | 0 | 64.7 | -123.4 | 62.9 | ||||||||
cash-flows.row.account-payables | 0 | -410.8 | 101.2 | 239.2 | ||||||||
cash-flows.row.other-working-capital | 0 | 281.4 | -489.7 | -338.1 | ||||||||
cash-flows.row.other-non-cash-items | 0 | -1128 | -1310.3 | -67.3 | ||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -5745.3 | -1703.2 | -944.3 | ||||||||
cash-flows.row.acquisitions-net | 0 | -2161.9 | -3240.9 | -352.7 | ||||||||
cash-flows.row.purchases-of-investments | 0 | -5392.8 | -5828.1 | -2409.6 | ||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 7010.4 | 6520 | 113.8 | ||||||||
cash-flows.row.other-investing-activites | 0 | 133.6 | 137 | 51 | ||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -6155.9 | -4115.2 | -3541.8 | ||||||||
cash-flows.row.debt-repayment | 0 | -2410.8 | -2334.4 | -1300.4 | ||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 1916.6 | 950.2 | ||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.other-financing-activites | 0 | 3294.2 | 1027.8 | 448.4 | ||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 883.4 | 610 | 98.2 | ||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 1311.4 | 0 | 0 | ||||||||
cash-flows.row.net-change-in-cash | 0 | 359.8 | -264.9 | 116.2 | ||||||||
cash-flows.row.cash-at-end-of-period | 0 | 616.1 | 256.3 | 521.3 | ||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 256.3 | 521.3 | 405.1 | ||||||||
cash-flows.row.operating-cash-flow | 0 | 4320.9 | 3240.3 | 3559.7 | ||||||||
cash-flows.row.capital-expenditure | 0 | -5745.3 | -1703.2 | -944.3 | ||||||||
cash-flows.row.free-cash-flow | 0 | -1424.3 | 1537 | 2615.5 |
Řádek výkazu zisku a ztráty
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 21976.8 | 16508.3 | 13122.1 | ||||||||
income-statement-row.row.cost-of-revenue | 0 | 8270.8 | 6170.6 | 4931.1 | ||||||||
income-statement-row.row.gross-profit | 0 | 13706 | 10337.6 | 8191 | ||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||
income-statement-row.row.other-expenses | 0 | 258.7 | 202.6 | 36.1 | ||||||||
income-statement-row.row.operating-expenses | 0 | 8958.4 | 5906.5 | 5063.8 | ||||||||
income-statement-row.row.cost-and-expenses | 0 | 17229.3 | 12077.1 | 9995 | ||||||||
income-statement-row.row.interest-income | 0 | 61.1 | 122.8 | 58 | ||||||||
income-statement-row.row.interest-expense | 0 | 305.4 | 160.3 | 293.1 | ||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -99.5 | -198.2 | -381.9 | ||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||
income-statement-row.row.other-operating-expenses | 0 | 258.7 | 202.6 | 36.1 | ||||||||
income-statement-row.row.total-operating-expenses | 0 | -99.5 | -198.2 | -381.9 | ||||||||
income-statement-row.row.interest-expense | 0 | 305.4 | 160.3 | 293.1 | ||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 1292.6 | 726.7 | 695.4 | ||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||
income-statement-row.row.operating-income | 0 | 4887.5 | 4558.7 | 3134 | ||||||||
income-statement-row.row.income-before-tax | 0 | 4849.1 | 4568.5 | 2790.2 | ||||||||
income-statement-row.row.income-tax-expense | 0 | 1190.9 | 1130.6 | 735.4 | ||||||||
income-statement-row.row.net-income | 0 | 3363.2 | 3326.8 | 2012.2 |
Často kladené otázky
Co je Krishna Institute of Medical Sciences Limited (KIMS.BO) celková aktiva?
Krishna Institute of Medical Sciences Limited (KIMS.BO) celková aktiva jsou 29413030000.000.
Jaký je roční obrat podniku?
Roční příjmy jsou N/A.
Jaké je ziskové rozpětí podniku?
Zisková marže firmy je 0.621.
Jaký je volný peněžní tok podniku?
Volný peněžní tok je 42.228.
Jaká je čistá zisková marže podniku?
Čistá zisková marže je 0.138.
Jaké jsou celkové tržby podniku?
Celkové příjmy jsou 0.209.
Co je Krishna Institute of Medical Sciences Limited (KIMS.BO) čistý zisk (čistý příjem)?
Čistý zisk (čistý příjem) je 3363220000.000.
Jaký je celkový dluh podniku?
Celkový dluh je 6781740000.000.
Jaké je číslo provozních nákladů?
Provozní výdaje jsou 8958440000.000.
Jaké je číslo peněžních prostředků firmy?
Peněžní prostředky podniku jsou 0.000.